|
1
|
Xue H, Ni P, Lin B, Xu H and Huang G:
X-ray repair cross-complementing group 1 (XRCC1) genetic
polymorphisms and gastric cancer risk: A HuGE review and
meta-analysis. Am J Epidemiol. 173:363–375. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis C, Siegel R, Bandi P and Jemal A:
Breast cancer statistics, 2011. CA Cancer J Clin. 61:409–418. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cao W, Wang X and Li JC: Hereditary breast
cancer in the Han Chinese population. J Epidemiol. 23:75–84. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen WQ, Zeng HM, Zheng RS, Zhang SW and
He J: Cancer incidence and mortality in china, 2007. Chin J Cancer
Res. 24:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gehrig S, Sami H and Ogris M: Gene therapy
and imaging in preclinical and clinical oncology: Recent
developments in therapy and theranostics. Ther Deliv. 5:1275–1296.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Noteborn MH, Verschueren CA, Zantema A,
Koch G and van der Eb AJ: Identification of the promotor region of
chicken anemia virus (CAV) containing a novel enhancer-like
element. Gene. 150:313–318. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Danen-Van Oorschot AA, Fischer DF,
Grimbergen JM, Klein B, Zhuang S, Falkenburg JH, Backendorf C, Quax
PH, Van der Eb AJ and Noteborn MH: Apoptin induces apoptosis in
human transformed and malignant cells but not in normal cells. Proc
Natl Acad Sci USA. 94:5843–5847. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O'Connor TP and Crystal RG: Genetic
medicines: Treatment strategies for hereditary disorders. Nat Rev
Genet. 7:261–276. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kobayashi K: Summary of recombinant human
serum albumin development. Biologicals. 34:55–59. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rhaese S, von Briesen H, Rübsamen-Waigmann
H, Kreuter J and Langer K: Human serum albumin-polyethylenimine
nanoparticles for gene delivery. J Control Release. 92:199–208.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shoae-Hassani A, Keyhanvar P, Seifalian
AM, Mortazavi-Tabatabaei SA, Ghaderi N, Issazadeh K, Amirmozafari N
and Verdi J: λ Phage nanobioparticle expressing apoptin efficiently
suppress human breast carcinoma tumor growth in vivo. PLoS One.
8:e799072013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maddika S, Mendoza FJ, Hauff K, Zamzow CR,
Paranjothy T and Los M: Cancer-selective therapy of the future:
Apoptin and its mechanism of action. Cancer Biol Ther. 5:10–19.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Noteborn MH, Todd D, Verschueren CA, de
Gauw HW, Curran WL, Veldkamp S, Douglas AJ, McNulty MS, van der Eb
AJ and Koch G: A single chicken anemia virus protein induces
apoptosis. J Virol. 68:346–351. 1994.PubMed/NCBI
|
|
15
|
Tavassoli M, Guelen L, Luxon BA and Gäken
J: Apoptin: Specific killer of tumor cells? Apoptosis. 10:717–724.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Backendorf C, Visser AE, de Boer AG,
Zimmerman R, Visser M, Voskamp P, Zhang YH and Noteborn M: Apoptin:
Therapeutic potential of an early sensor of carcinogenic
transformation. Annu Rev Pharmacol Toxicol. 48:143–169. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Los M, Panigrahi S, Rashedi I, Mandal S,
Stetefeld J, Essmann F and Schulze-Osthoff K: Apoptin, a
tumor-selective killer. Biochim Biophys Acta. 1793:1335–1342. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guan GF, Zhao M, Liu LM, Jin CS, Sun K,
Zhang DJ, Yu DJ, Cao HW, Lu YQ and Wen LJ: Salmonella typhimurium
mediated delivery of apoptin in human laryngeal cancer. Int J Med
Sci. 10:1639–1648. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
van der Eb MM, Pietersen AM, Speetjens FM,
Kuppen PJ, van de Velde CJ, Noteborn MH and Hoeben RC: Gene therapy
with apoptin induces regression of xenografted human hepatomas.
Cancer Gene Ther. 9:53–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhuang SM, Shvarts A, van Ormondt H,
Jochemsen AG, van der Eb AJ and Noteborn MH: Apoptin, a protein
derived from chicken anemia virus, induces p53-independent
apoptosis in human osteosarcoma cells. Cancer Res. 55:486–489.
1995.PubMed/NCBI
|
|
21
|
Backendorf C, Visser AE, de Boer AG,
Zimmerman R, Visser M, Voskamp P, Zhang YH and Nobetorn M: Apoptin:
Therapeutic potential of an early sensor of carcinogenic
transformation. Annual review of pharmacology and toxicology.
48:143–69. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Peters T Jr: All About Albumin:
Biochemistry, Genetics, and Medical Applications. 1st. Academic
Press; San Diego, CA: 1996
|
|
23
|
Zhao XN, Liu Y, Niu LY and Zhao CP:
Spectroscopic studies on the interaction of bovine serum albumin
with surfactants and apigenin. Spectrochim Acta A Mol Biomol
Spectrosc. 94:357–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abdi K, Nafisi SH, Manouchehri F, Bonsaii
M and Khalaj A: Interaction of 5-Fluorouracil and its derivatives
with bovine serum albumin. J Photochem Photobiol B. 107:20–26.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aleman BM, Moser EC, Nuver J, Suter TM,
Maraldo MV, Specht L, Vrieling C and Darby SC: Cardiovascular
disease after cancer therapy. EJC Suppl. 12:18–28. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Visovsky C: Treatment considerations for
the management of patients with hormone receptor-positive
metastatic breast cancer. J Adv Pract Oncol. 5:321–330.
2014.PubMed/NCBI
|
|
27
|
Wang MJ: Professor Hope S. Rugo: Reversing
resistance and hormone therapy for metastatic breast cancer. Chin
Clin Oncol. 3:512014.PubMed/NCBI
|
|
28
|
Jerusalem G, Rorive A and Collignon J: The
drug of the month: Everolimus (Afinitor) for the treatment of
metastatic breast cancer. Rev Med Liege. 69:510–517. 2014.(In
French). PubMed/NCBI
|
|
29
|
Bergen E, Berghoff AS, Rudas M, Dubsky P,
De Vries C, Sattlberger C, Mader RM, Zagouri F, Sparber C, Fitzal
F, et al: Taxanes plus trastuzumab compared to oral vinorelbine
plus trastuzumab in HER2-overexpressing metastatic breast cancer.
Breast Care (Basel). 9:344–348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Domschke C and Schuetz F: Side effects of
bone-targeted therapies in advanced breast cancer. Breast Care
(Basel). 9:332–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Greenlee H, Balneaves LG, Carlson LE,
Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen
A, et al: Society for Integrative Oncology: Clinical practice
guidelines on the use of integrative therapies as supportive care
in patients treated for breast cancer. J Natl Cancer Inst Monogr.
2014:346–358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yoo C, Kim SB, Ahn JH, Kim JE, Jung KH,
Gong GY, Son BH, Ahn SH, Ahn SD, Kim HH, et al: A randomized phase
II trial of capecitabine plus vinorelbine followed by docetaxel
versus Adriamycin plus cyclophosphamide followed by docetaxel as
neoadjuvant chemotherapy for breast cancer. Cancer Res Treat.
47:406–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
An S, Nam K, Choi S, Bai CZ, Lee Y and
Park JS: Nonviral gene therapy in vivo with PAM-RG4/apoptin as a
potential brain tumor therapeutic. Int J Nanomedicine. 8:821–834.
2013.PubMed/NCBI
|
|
34
|
Liu L, Wu W, Zhu G, Liu L, Guan G, Li X,
Jin N and Chi B: Therapeutic efficacy of an hTERT promoter-driven
oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Int J Mol Med. 30:747–754. 2012.PubMed/NCBI
|
|
35
|
Pan Y, Fang L, Fan H, Luo R, Zhao Q, Chen
H and Xiao S: Antitumor effects of a recombinant pseudotype
baculovirus expressing Apoptin in vitro and in vivo. Int J Cancer.
126:2741–2751. 2010.PubMed/NCBI
|
